CASI Pharmaceuticals, Inc. ( CASI) - Stock Earnings
Stock symbol CASI is outdated, potentially delisted? Maybe it is available on other exchange?
CASI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -10.8 million USD | 6.2 million USD |
| 2025Q2 | -13.4 million USD | 4.2 million USD |
| 2025Q3 | -10.9 million USD | 3.1 million USD |
| 2026Q2 Est. | — | — |
CASI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -41.0 million USD | 43.1 million USD |
| 2023 | -26.9 million USD | 33.9 million USD |
| 2024 | -39.3 million USD | 28.5 million USD |
| 2026 Est. | — | — |
CASI
Price: $0.21
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 21900
Ebitda: -1.6 millionMarket Capitalization: 3.2 million